Press Release
Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months
Media
Aragen Life Sciences: Trusted R&D and Manufacturing Partner
Media
Aragen shares 2026 predictions
Media
Incidence of Spontaneous and Urethane-Induced Tumors in a 26-Week Carcinogenicity Study in Tg.rasH2 Mice Sourced From CLEA, Japan
Media
Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders
Media
Globalising ADC development in the US and beyond
Press Release
Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 Months
Media
Aragen Life Sciences: Trusted R&D and Manufacturing Partner
Media
Aragen shares 2026 predictions
Media
Incidence of Spontaneous and Urethane-Induced Tumors in a 26-Week Carcinogenicity Study in Tg.rasH2 Mice Sourced From CLEA, Japan
Media
Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders
Media
Globalising ADC development in the US and beyond
March 23-25, 2026
San Diego, USA
March 23-26, 2026
New York, USA
March 23-25, 2026
San Diego, USA
March 23-26, 2026
New York, USA
Key brand assets for use across all communication.
Quick snapshot of our company, including relevant facts and numbers.
